Cargando…

Minimal dosing of leukocyte targeting TRAIL decreases triple-negative breast cancer metastasis following tumor resection

Surgical removal of the primary tumor is a common practice in breast cancer treatment. However, postsurgical metastasis poses an immense setback in cancer therapy. Considering that 90% of cancer-related deaths are due to metastasis, antimetastatic therapeutic strategies that can target disseminating...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jyotsana, Nidhi, Zhang, Zhenjiang, Himmel, Lauren E., Yu, Fang, King, Michael R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656540/ https://www.ncbi.nlm.nih.gov/pubmed/31355333 http://dx.doi.org/10.1126/sciadv.aaw4197

Ejemplares similares

Overcoming TRAIL-resistance by sensitizing prostate cancer 3D spheroids with taxanes
por: Grayson, Korie A., et al.
Publicado: (2021)

Mass Action Kinetic Model of Apoptosis by TRAIL-Functionalized Leukocytes
por: Lederman, Emily E., et al.
Publicado: (2018)

Secretory leukocyte protease inhibitor (SLPI) as a potential target for inhibiting metastasis of triple-negative breast cancers
por: Kozin, Sergey V., et al.
Publicado: (2017)

Synergistic antitumor effects of circularly permuted TRAIL with doxorubicin in triple-negative breast cancer: Circularly permuted TRAIL with Dox in TNBC
por: Liu, Jia, et al.
Publicado: (2023)

Glutamine metabolism regulates FLIP expression and sensitivity to TRAIL in triple-negative breast cancer cells
por: Mauro-Lizcano, Marta, et al.
Publicado: (2018)

CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death
por: Chung, Alexander H., et al.
Publicado: (2019)

Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer Therapy
por: Kundu, Manjari, et al.
Publicado: (2022)

Molecular Characteristics and Metastasis Predictor Genes of Triple-Negative Breast Cancer: A Clinical Study of Triple-Negative Breast Carcinomas
por: Kuo, Wen-Hung, et al.
Publicado: (2012)

Micelle-in-Liposomes for Sustained Delivery of Anticancer Agents That Promote Potent TRAIL-Induced Cancer Cell Apoptosis
por: Zhang, Zhenjiang, et al.
Publicado: (2020)

TRAIL-coated leukocytes to kill circulating tumor cells in the flowing blood from prostate cancer patients
por: Ortiz-Otero, Nerymar, et al.
Publicado: (2021)

The Impact of COVID-19 on Cancer Risk and Treatment
por: Jyotsana, Nidhi, et al.
Publicado: (2020)

Gastric Metastasis of Triple Negative Invasive Lobular Carcinoma
por: Geredeli, Caglayan, et al.
Publicado: (2015)

Untangling Triple-Negative Breast Cancer Molecular Peculiarity and Chemo-Resistance: Trailing Towards Marker-Based Targeted Therapies
por: Kanwal, Bushra
Publicado: (2021)

Effective in vitro delivery of paclitaxel by nanocargo of mesoporous polycaprolactone against triple negative breast cancer cells by minimalizing drug dose
por: Medhi, Himadri, et al.
Publicado: (2020)

Triple-Negative Breast Cancer
por: Chu, Quyen D., et al.
Publicado: (2012)

Rad51 supports triple negative breast cancer metastasis
por: Wiegmans, Adrian P, et al.
Publicado: (2014)

Wnt signaling in triple negative breast cancer is associated with metastasis
por: Dey, Nandini, et al.
Publicado: (2013)

Antimicrobial exposure is associated with decreased survival in triple-negative breast cancer
por: Ransohoff, Julia D., et al.
Publicado: (2023)

DUSP1 promoter methylation in peripheral blood leukocyte is associated with triple-negative breast cancer risk
por: Li, Jing, et al.
Publicado: (2017)

Regulation of Cancer Metastasis by TRAIL/Death Receptor Signaling
por: Oh, You-Take, et al.
Publicado: (2021)

TRAIL and Taurolidine induce apoptosis and decrease proliferation in human fibrosarcoma
por: Daigeler, Adrien, et al.
Publicado: (2008)

Trail without Catheter after Transurethral Resection of Prostate: Clamp It or Not?
por: Talreja, Vikash, et al.
Publicado: (2016)

MicroRNA-223 Increases the Sensitivity of Triple-Negative Breast Cancer Stem Cells to TRAIL-Induced Apoptosis by Targeting HAX-1
por: Sun, Xu, et al.
Publicado: (2016)

Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer
por: Wang, Shengpeng, et al.
Publicado: (2017)

Osteoprotegerin expression in triple-negative breast cancer cells promotes metastasis
por: Weichhaus, Michael, et al.
Publicado: (2014)

Peptide density targets and impedes triple negative breast cancer metastasis
por: Liu, Daxing, et al.
Publicado: (2018)

Endothelial Cells Potentially Participate in the Metastasis of Triple-Negative Breast Cancer
por: Ma, Yanfei, et al.
Publicado: (2022)

Syntelin inhibits triple-negative breast cancer cell proliferation and metastasis
por: Mullen, McKay, et al.
Publicado: (2021)

GPR110 promotes progression and metastasis of triple-negative breast cancer
por: Nam, Hye-Jung, et al.
Publicado: (2022)

Diagnostic and Prognostic Nomograms for Lung Metastasis in Triple-Negative Breast Cancer
por: Wang, Jianguo, et al.
Publicado: (2022)

Insulin receptor is implicated in triple-negative breast cancer by decreasing cell mobility
por: Yang, Ying, et al.
Publicado: (2021)

The Synergistic Effects of Low Dose Fluorouracil and TRAIL on TRAIL-Resistant Human Gastric Adenocarcinoma AGS Cells
por: Zhu, Hong, et al.
Publicado: (2013)

Normal Thymocyte Negative Selection in TRAIL-deficient Mice
por: Cretney, Erika, et al.
Publicado: (2003)

A Trail to Diagnosis—Finding the Primary Lesions of Bone Metastasis
por: Shah, Ejaz, et al.
Publicado: (2022)

Minimally invasive resection of synchronous triple primary tumors of the esophagus, lung, and thymus: A case report
por: Song, Xiao, et al.
Publicado: (2016)

Dihydroartemisinin-Transferrin Adducts Enhance TRAIL-Induced Apoptosis in Triple-Negative Breast Cancer in a P53-Independent and ROS-Dependent Manner
por: Zhou, Xinyu, et al.
Publicado: (2022)

In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs
por: Ashley, D M, et al.
Publicado: (2008)

In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs
por: Ashley, D M, et al.
Publicado: (2009)

Engineering of Exosomes to Target Cancer Metastasis
por: Zhang, Zhenjiang, et al.
Publicado: (2019)

Novel genes associated with lymph node metastasis in triple negative breast cancer
por: Mathe, Andrea, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_k7agaba6ia29q5em3r594q5b2c